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Abstract: Traumatic brain injury (TBI) can lead to impaired cognition and memory consolidation.
The acute phase (24–48 h) after TBI is often characterized by neural dysfunction in the vicinity of the
lesion, but also in remote areas like the contralateral hemisphere. Protein homeostasis is crucial for
synaptic long-term plasticity including the protein degradation systems, proteasome and autophagy.
Still, little is known about the acute effects of TBI on synaptic long-term plasticity and protein
degradation. Thus, we investigated TBI in a controlled cortical impact (CCI) model in the motor and
somatosensory cortex of mice ex vivo-in vitro. Late long-term potentiation (l-LTP) was induced by
theta-burst stimulation in acute brain slices after survival times of 1–2 days. Protein levels for the
plasticity related protein calcium/calmodulin-dependent protein kinase II (CaMKII) was quantified
by Western blots, and the protein degradation activity by enzymatical assays. We observed missing
maintenance of l-LTP in the ipsilateral hemisphere, however not in the contralateral hemisphere after
TBI. Protein levels of CaMKII were not changed but, interestingly, the protein degradation revealed
bidirectional changes with a reduced proteasome activity and an increased autophagic flux in the
ipsilateral hemisphere. Finally, LTP recordings in the presence of pharmacologically modified protein
degradation systems also led to an impaired synaptic plasticity: bath-applied MG132, a proteasome
inhibitor, or rapamycin, an activator of autophagy, both administered during theta burst stimulation,
blocked the induction of LTP. These data indicate that alterations in protein degradation pathways
likely contribute to cognitive deficits in the acute phase after TBI, which could be interesting for future
approaches towards neuroprotective treatments early after traumatic brain injury.
Keywords: traumatic brain injury; long-term potentiation; plasticity related proteins; proteasome;
autophagy, somatosensory cortex
1. Introduction
Traumatic brain injury (TBI) is one of the major global causes of morbidity and mortality in
adults under 40 years of age [1,2]. Focal TBI leads to brain damage with variable lesion patterns
including a necrotic lesion center surrounded by brain edema, vascular injury and diffuse axonal injury,
all contributing to the heterogeneous clinical outcome [3,4]. Furthermore, focal TBI induces secondary
brain damage during the first 48 h after TBI, mainly caused by inflammatory reactions, reactive gliosis
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as well as increased phagocytic activity and apoptosis [4–8]. An altered neurotransmitter and calcium
release resulted in changes of neuronal network activity even in cells primarily unaffected by the
TBI [9]. Furthermore, the distant contralateral brain hemisphere was shown to react to focal, ipsilateral
impacts with regard to changes in gamma-aminobutyric acid (GABA) signaling and increased network
excitability in mouse models [10,11] as well as in imaging studies in humans [12]. Post-traumatic,
adaptive cellular processes affect the functional reorganization of the cortical networks as well as
the neuronal loss resulting in either beneficial or detrimental effects with respect to the neurological
outcome [13].
Reported symptoms after TBI include cognitive deficits, especially regarding consolidation of new
information. Late long-term potentiation (l-LTP), as the persistent enhancement of synaptic transmission,
is assumed to be the cellular correlate of learning and memory formation [14,15]. Expression of l-LTP is
based on activity-induced calcium influx through N-methyl-d-aspartic acid (NMDA) receptors [16,17] and
activation of protein synthesis processes [18]. Through modulation of postsynaptic protein homeostasis
and architecture of the postsynaptic density [19], a selective strengthening of synapses and thus, memory
formation, can be achieved, for example by phosphorylation of postsynaptic modulators, so called
plasticity related proteins. It is well known that phosphorylation of the calcium/calmodulin-dependent
protein kinase II (CaMKII) leads to the potentiation of existing receptors [20], activation of specific
synapses [18,21] and strengthening of dendritic spines through F-actin polymerization [22]. Furthermore,
the balance of two protein degradation systems, autophagy and proteasome activity, is crucial to
achieve synaptic plasticity [23]. Decreased activation of the proteasome is related to impaired synaptic
plasticity [23–25]. Moreover, the experimental activation of autophagy with mammalian target of
rapamycin (mTOR) inhibitors such as rapamycin [26] as well as nanoparticles [27] suppresses LTP and
influences neurotransmission [28]. Recent studies suggest that the differential activation of these two
protein degradation systems is mediated by heat shock protein 70 (Hsp 70) [29,30]. Hsp 70 is activated
through co-chaperones beclin2-associated anthanogenes (BAG). While BAG1 modulates Hsp 70 increasing
proteasome activity, BAG3 controls BAG3-mediated selective macroautophagy [29–31]. Strikingly, shifts
in BAG concentrations could be linked to pathological changes, e.g., in ageing [29,32]. In TBI, several
synaptic properties appear to be affected leading to changes in receptor and transmitter concentrations
as well as specific cell survival [9], as a consequence of dysregulation through excitotoxicity. Proteasome
activation is impaired during the first week post-lesion [33] with increasing levels of proteolytic activity
at later time points post-lesion [34]. Autophagy activity as indicated by LC3-II is increased reaching
maximum levels three days post-TBI [35–37]. However, so far it is not known, how a focal TBI affects
l-LTP in the ipsilateral and contralateral hemisphere of the somatosensory cortex at all, and if and
how protein degradation systems as well as plasticity related proteins are involved in any potential
changes of l-LTP during the acute, early phase (24–48 h) after the injury. Here, we present evidence
for specific alterations in the protein homeostasis and in long-term synaptic plasticity already 24-48 h
after TBI. Interestingly, the impaired l-LTP was observed exclusively in the ipsilateral hemisphere of
the somatosensory cortex. Our results provide new information on the mechanisms underlying early
cognitive impairments observed in patients after traumatic brain injury.
2. Results
2.1. Lesion Expansion in the Acute Phase after Controlled Cortical Impact (CCI)
In accordance with our previous study [11], the controlled cortical impact (CCI) induced a cortical
lesion in the motor- (M1 and M2) as well as in somatosensory (S1) cortex of the mice. It measured
1.5–2 mm in mediolateral extent and extended along the rostrocaudal axis between 0 and −2 mm
relative to bregma. The lesion size and location was highly reproducible and affected all cortical layers,
as shown by the representative Nissl-stained coronal section of a CCI-treated brain (Figure 1A).
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Figure 1. Histology of the controlled cortical impact (CCI) lesion. (A) Representative example of a Nissl
stained coronal section of the sensorimotor cortex from a 20-day-old mouse at 1 day post-CCI. The black
dotted squares represent the perforated microelectrode array (pMEA) chip position for monitoring
extracellular signals, the recording electrodes were located in supra-granular layers 2/3. We recorded
1 mm lateral from the border of the lesion and in the homotopic region of the contralateral hemisphere
and sham animals. (B) Some slices were treated with an in situ TUNEL assay to detect early signs of
apoptosis. The resulting confocal images were taken in specific areas of the cortical slice as shown
in Figure 1A (see arrows) and are shown at a higher magnification (the white scale bar corresponds
to 100 µm). B1 shows an example of a confocal image of the homotopic area of the contralateral
hemisphere, images in B2 were taken from the lesion area in the ipsilateral hemisphere, while images in
B2 were derived at 1 mm distance from the border of the lesion in the ipsilateral hemisphere. Note that
TUNEL positive cells were detected at the close border of the lesion (white dashed line). In contrast,
at more distant areas ipsilateral (1 mm distance to the lesion) and contralateral, the MEA-recording
sites revealed almost no signs of apoptosis.
First, we evaluated an early TBI-induced potential spreading of cell death (apoptosis) in the areas
of interest and performed in situ TUNEL labeling of DNA-strand breaks in all experimental groups.
Apoptosis-positive cells could be identified mediolaterally up to a distance of 300–400 µm from the
border of the lesion (Figure 1B2). Interestingly, the areas of our electrophysiological recordings in both,
ipsi- and contralateral hemisphere revealed no significant expression of cell death in the early phase of
TBI after 24 and 48 h (Figure 1B1,B3).
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2.2. Impairment of Long-term Synaptic Plasticity 1 to 2 Days Post-Lesion
Changes in initiation, regulation and maintenance of synaptic plasticity are crucial for functional
reorganization processes in the post-traumatic brain. In this study, our focus was the expression
and maintenance of l-LTP, since processes like protein synthesis and degradation might particularly
influence l-LTP. Acute cortical slices were selected between bregma −0.5 and −1.5 mm in 1–2 days
post-CCI animals. After positioning the 32-channel perforated microelectrode array (pMEA) chip in
the supragranular layers and 1 mm away from the border of the lesion or in homotopic areas both
contralaterally and in sham animals (Figure 1B), we recorded theta-burst stimulation (TBS)-induced
l-LTP for a duration of 180 min (Figure 2A,B). As further described in the Methods section, TBS is an
established repetitive high-frequency stimulation protocol for induction of synaptic plasticity.
Figure 2. Impairment of long-term synaptic plasticity (late long-term potentiation (l-LTP)) in the early
phase after traumatic brain injury (TBI). (A) Representative voltage traces of evoked extracellular field
potentials (FPs) recorded before (Pre-TBS, baseline, 1 in (B)) and after electrical theta-burst stimulation
(TBS) (post-TBS, maintenance, 3 in (B)) and under different experimental conditions at 1-2 days post-TBI
(sham: n = 8 from 8 mice; ipsilateral: n = 7 from 7 mice; contralateral: n = 8 from 8 mice). (B) Time
course of relative local field potentials (LFPs) amplitude pre- and post-TBS. After baseline recording (1),
TBS protocol was applied and LFPs were recorded for 180 min; data points represent mean values of
the electrophysiological recordings under different conditions (sham: n = 8 from 8 mice; ipsilateral:
n = 7 from 7 mice; contralateral: n = 8 from 8 mice) relative to the recordings of the individual baseline,
the error bars represent standard error of mean (SEM). The dashed rectangles represent the time
windows considered for the induction (2: first 20 min of recording) and the maintenance of l-LTP
(3: last 20 min of recording), as visualized in (C). The lesion significantly decayed the expression of
ipsilateral l-LTP over the course of recording. (C) Scatter plots showing the induction (2 in (B)) and
the maintenance (3 in (B)) of l-LTP in the different experimental conditions over a recording period of
20 min; data points represent the relative values of baseline stimulation acquired during the induction
phase (C left) in the first 20 min post-TBS and the maintenance phase (C right) during the last 20 min;
mean and SEM are indicated by the black horizontal lines. The asterisks indicate the significance of the
tested data in one-way analysis of variance (ANOVA) and post hoc least significant difference (LSD),
significantly different values are indicated as *: p < 0.05, **: p < 0.01.
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Only measurements with a significant increase of FP-amplitudes in the first 20 min after TBS in
all experimental conditions, when compared to the baseline signals, were included in the analysis.
However, FP-amplitudes during induction of LTP were not significantly reduced in the ipsilateral
hemisphere (119.3 ± 5.5%) (Figure 2C). With respect to the maintenance of l-LTPs (160 to 180 min
post-TBS) we observed exclusively a significant reduction of the FP-amplitudes in the ipsilateral cortex
when compared to sham-operated animals (sham: 116.9 ± 11.3%; ipsilateral: 84.6 ± 8.1%, p = 0.05;
contralateral: 100.7 ± 7.3%) (Figure 2C). Furthermore, within one LTP experiment the ipsilateral cortex
revealed a significant decay in the strength of l-LTP from the induction to its maintenance (p = 0.0066)
(Figure 2C). Interestingly, the contralateral cortex revealed no changes in the maintenance of l-LTP in
our recordings (Figure 2C).
2.3. Dysregulation of the Phosphorylation Level of Calcium-Calmoduline Dependent Kinase II α (CaMKIIα) 1
to 2 Days Post-Traumatic Brain Injury (TBI)
In search for potential cellular mechanisms underlying the observed changes in the strength of
LTP induction and maintenance early after TBI, we investigated processes of protein homeostasis
in the cortical tissue, initially focusing on changes in the level of the plasticity related protein
calcium-calmoduline dependent kinase II α (CaMKIIα). Cortical tissue was collected from the
same brain area where the electrophysiological recordings were performed. Quantification of the
non-phosphorylated form of CaMKIIαdid not disclose significant changes in neither of the hemispheres,
although a tendency for a decreased CaMKIIα expression was observed ipsilaterally (sham: 1; ipsilateral:
0.7 ± 0.1, p = 0.16; contralateral: 0.9 ± 0.09) (Figure 3A).
Figure 3. Phosphorylation levels of calcium-calmodulin dependent kinase II (CaMKIIα) in the
acute period after TBI are not significantly altered. Exemplary Western blots of CaMKIIα (A) and
phosphorylated CaMKII (pCaMKII) (B). In the lower section, protein levels from brain lysates of the
respective cortical areas of interest are depicted in scatter plots for CaMKIIα (n = 6 from 6 mice for each
experimental condition) and pCaMKII (n = 6 from 6 mice for each experimental conditions). Expression
levels were quantified after normalization to the housekeeping protein GAPDH. The dashed line
represents the CaMKIIα protein level in sham-operated animals, normalized to 1, the data points in the
scatter plots represent the relative values for protein expression levels in the ipsilateral or contralateral
hemisphere per animal, bars and error bars represent mean and SEM. For statistical analysis pairwise
Mann-Whitney-U test was performed, they revealed no significant differences.
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When activated after synaptic stimulation like our tetanic LTP stimulation protocol, CaMKII is
selectively phosphorylated on the amino-acid Thr286. Since during TBI the described calcium inflow
could result in undirected phosphorylations, we examined the levels of CaMKII phosphorylation
isoforms α and β (Figure 3B). In a sham condition, the basal phosphorylation levels of both isoforms
(particularly pCaMKIIα) were low since no experimental l-LTP induction was performed before
tissue collection. Albeit a trend to increase, basal phosphorylation levels of both pCaMKIIα (sham: 1;
ipsilateral: 3.3 ± 1.7; contralateral: 1.6 ± 0.6) and pCaMKIIβ (sham: 1; ipsilateral: 3.4 ± 2.4; contralateral:
1.2 ± 0.9) were not significantly altered after the lesion (Figure 3B). Altogether, these results suggest
that alterations of CaMKII expression and activation are not responsible for the observed ipsilateral
impaired expression of l-LTP.
2.4. The TBI-Induced Impairment of Late Long-Term Potentiation (l-LTP) is Mediated by Altered Protein
Degradation Systems
Processes of l-LTP and the associated activation of the CaMKII have been tightly linked to
protein homeostasis. Particularly, protein degradation plays an important role in synaptic plasticity
by participating in both synapse formation and synapse elimination induced by neuronal activity [38].
Therefore, we investigated the status of two important protein degradation systems after lesion,
the proteasome and the autophagy. The proteasome peptidase activity and the autophagic flux assays
were investigated to quantify the activity of the respective pathways. Tissue samples were collected in
each hemisphere in TBI-treated mice and in sham-operated animals at 2 days post-injury. The proteasome
activity was measuered by an assay (see Methods). This revealed an impaired ubiquitin-dependent
protein degradation in both hemispheres after TBI when compared to sham (ipsilateral: 0.75 ± 0.08, sham
vs. ipsi: p = 0.02; contralateral: 0.74 ± 0.07, sham vs. contra: p = 0.019) (Figure 4A).
Figure 4. Altered protein degradation systems early after lesion. (A) Scatter plots representing the
relative proteasome activity (9 mice for each experimental condition) measured in the ipsilateral area of
electrophysiological recordings at 2 days post CCI. Data points represent the values for each animal per
condition for protein expression levels in the ipsilateral or contralateral hemisphere relative to sham
data. Mean and SEM are indicated by the bar plots and error bars. (B) Representative Immunoblot
of the autophagosomal marker, light chain 3 (LC3) protein, from the cortical area of interest. Both
cytosolic (LC3 I) and phosphatidylethanolamine conjugated forms of LC3 (LC3 II) were detected but
only LC3 II was quantified in (B) after normalization to the housekeeping protein Tubulin. Note the
impaired proteasome activity, while autophagy is increased compared to sham animals at the same
time suggesting a shift in protein degradation systems. One-way ANOVA and D’Agostino and Pearson
normality tests disclosed significant differences of proteasome activity in the ipsi- and contralateral
hemisphere, levels of significance are indicated as *: p < 0.05.
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The second protein degradation system, the autophagic flux, was measured in acute brain slices
of 3 mice for each experimental condition by detection of the LC3-II flux induced by bath application of
rapamycin (Figure 4B). In contrast to the other protein degradation system (Figure 4A), the autophagic
flux reacted differently to TBI: the CCI treated ipsilateral hemisphere showed an increase (3.2 ± 1.1,
sham vs. ipsi: p = 0.037) in the autophagic flux compared to the sham condition, while the contralateral
cortex showed a significant decrease in LC3-II flux (0.47 ± 0.3, sham vs. contra: p = 0.04).
Next, we investigated the effects of the the detected TBI-induced alterations in the two protein
degradation systems on synaptic plasticity. To do so, the strength of the proteasome and of the
autophagy system were pharmacologically modified in brain sliced to mimic TBI situation in an
otherwise untreated mouse brain by using either 10 µM MG132 for blocking the proteasome or 1 µM
rapamycin for enhancing the autophagy. The expression of LTP was recorded in presence of one or the
other pharmacological agent (Figure 5A,B).
Figure 5. Pharmacological modulation of the two protein degradation systems induced TBI-like changes
in l-LTP. (A) Representative voltage traces of evoked FPs recorded before (Pre-TBS, baseline, 1 in (B))
and after electrical TBS stimulation (post-TBS, induction, 2 in (B)) and under different pharmacological
conditions. Cortical slices were used under control conditions (normal artificial cerebrospinal fluid
(aCSF), control: n = 9 from 9 mice), in presence of MG132, a proteasome inhibitor (n = 4 from 4 mice),
and in presence of rapamycin, an activator of autophagy (n = 6 from 6 mice). (B) Time course of relative
FPs amplitudes pre- and post-TBS, data points represent the mean values for each condition (control:
n = 9, MG132: n = 4, rapamycin: n = 6) relative to the individual recording’s baseline, error bars
represent the SEM. The dashed rectangles represent the time windows considered for the induction
phase of l-LTP (2: first 20 min of recording), as visualized in (C). Note, impairment of the proteasome
or enhancement of autophagy suppressed the expression of l-LTP in wild type slices over the course
of recording. (C) Scatter plot showing the abolished l-LTP under both pharmacological agents over
a recording period of 20 min; data points represent the relative mean values for the first 20 min,
the induction phase of LTP, for each recording; the mean and SEM are indicated by the black horizontal
bars and error bars. The asterisks indicate the significance of the tested data in one-way ANOVA and
post hoc LSD, significantly different values are indicated as **: p < 0.01, ***: p ≤ 0.001.
During the first 30 min after induction of our LTP-stimulation protocol, no induction of LTP
could be observed in neither of the two pharmacological conditions when compared to control
slices in normal artificial cerebrospinal fluid (aCSF) (control: 143.2 ± 6.2%; MG132: 102.4 ± 4.5%,
pctrl/MG132 = 0.003; rapamycin: 92.0 ± 7.8%, pctrl/rapamycin = 0.0003) (Figure 5B,C). Since no potentiation
occurred, the recordings were stopped at 30 min post-TBS. Taken together, these data suggest that
the observed impairment of long-term synaptic plasticity (l-LTP) early after TBI in the ipsilateral
hemisphere is strongly correlated with specific dynamic changes in the two protein degradation
systems, the proteasome and autophagic flux.
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3. Discussion
The acute phase following TBI is characterized in part by specific adaptive cellular processes
within the surviving neuronal networks, and this is highly relevant for the final clinical outcome in
TBI-patients, e.g., for cognitive and motoric rehabilitation [9]. Still, these mechanisms are not fully
understood. We have recently shown that a focal cortical brain injury led to network hyperexcitability
in the contralateral hemisphere as early as 24–48 h post-lesion and interestingly, it induced changes
in GABAergic functions as well as in the subunit-composition of GABA-receptors on the m-RNA
level [10,11]. Here, we focused on the balance of protein homeostasis, which is also crucial for neuronal
function, especially for processes of synaptic plasticity: late-onset neural dysfunction following TBI
was associated with changes in protein homeostasis and protein degradation, which might lead to
the development of neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s disease
in humans [39–43] and in experimental mouse models [44]. Furthermore, even in healthy brains,
synaptic plasticity is affected by a singular modification of one protein degradation pathway [23–25].
Interestingly, in this context a regulatory mechanism was identified contrarily linking both protein
degradation systems, proteasome and autophagy, through heat-shock proteins [31]. This regulatory
mechanism could be shown to be influenced by processes such as ageing [30,32], and could be
similarly affected in pathological conditions such as trauma. Hence, the different modes of protein
degradation could be interesting targets for early modification of acute TBI, as clinically approved
medications, such as rapamycin interacting with autophagy, are already in clinical use for completely
different pathologies.
3.1. Traumatic Brain Injury Induced an Early Impairment of Long-Term Synaptic Plasticity
We induced LTP in acute brain slices ex-vivo in-vitro with a TBS stimulation protocol, which is
well established in our lab [45–47], and was modified in the present study to achieve stable potentiation
for more than 120 min (l-LTP). One main result of our experiments is that during the early acute phase
after TBI, maintenance of LTP in the ipsilateral hemisphere is significantly reduced in comparison to
sham-operated animals. So far, research on TBI-induced changes in LTP led to controversial results.
On the one hand, several electrical membrane properties mediating the action potential firing and
the input resistance were reported to be changed [48], and the glutamatergic neurotransmission was
increased [49]. On the other hand, hippocampal synaptic plasticity was reduced during the acute
phase post lesion in rats [50] as well as at later time points [51,52]. One major parameter contributing
to the different results is distance of the recording from the center of the injury [47]. Our results here
complement these findings and indicate that synaptic plasticity at a distance of 1.5 mm from the border
of the lesion in the ipsilateral hemisphere is impaired. Excessive neuronal hyperexcitability following
focal brain injuries [48,49] may result in an imbalance of the transmitter systems that has been linked
to impaired LTP before [8]. Furthermore, we showed in our TUNEL staining that although there was
apoptosis found in the immediate vicinity of the lesion, there was no evidence for apoptosis in the
adjacent recording areas, confirming that changes in electrophysiological measurements are unlikely
to be a result of direct cellular damage, at least in the early phase after TBI.
In contrast, in the contralateral hemisphere no significant impairment of maintenance of LTP was
observed while the induction of LTP was indeed, significantly reduced. Recent research, also from our
lab, has investigated the importance of diaschisis in TBI [10,11] showing changed electrophysiological
parameters in the contralateral hemisphere which are considered to contribute to recovery processes
or, at least, maintain network stability in the ipsilateral hemisphere. In line with this hypothesis are the
findings in the present study indicating that although initial potentiation is altered compared to sham,
an overall maintenance of potentiation can be achieved as the undamaged contralateral hemisphere is
not detrimentally affected by the lesion, but could rather reveal a compensatory function in this context.
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3.2. Expression of Plasticity Related Proteins Is Not Significantly Altered Early after TBI
One major theory for maintenance of LTP is the “synaptic tagging and capture” hypothesis
suggesting the importance of plasticity related proteins in the post-synapse for the maintenance
of LTP [19]. After TBI, strikingly, the activation of regulatory proteins is often altered through
phosphorylation which may be affected by post-traumatic increased calcium influx and thus, interfere
with the function of protein signaling cascades. CaMKIIα is a major plasticity related protein involved
in intracellular signaling pathways leading to differential synaptic strengthening [18,19,21], and it has
been linked to proteasome activity as well [38] making it an interesting target protein for investigation
of protein homeostasis. Our data suggest that the expression of CaMKIIα is not significantly altered
post-TBI, although we observed a trend for reduced expression in the ipsilateral hemisphere. As we
did not perform any stimulation protocols to induce LTP in the probes used for the Western blots,
we expected a relatively low level of phosphorylation of CaMKII in sham animals. In contrast,
we expected a TBI-induced intracellular calcium influx, which may last up to four days after CCI [53]
and may potentially lead to a relatively higher level of phosphorylation in CCI animals, even without
LTP induction. Interestingly, the detection of phosphorylated, thus activated, CaMKIIα was very
variable. Although we observed a tendency for increased phosphorylation levels under conditions after
TBI, especially in probes collected from the ipsilateral hemisphere, the unexpectedly high variability
prevented any significant result of this experiment. However, our finding is in line with a study
performed by use of a different TBI model, showing no upregulation of CaMKIIα phosphorylation in
the ipsilateral hemisphere [54].
These data indicate that changes in long-term synaptic plasticity related to CaMKIIα activation
are unlikely to be causally attributed to the impaired LTP observed in the electrophysiological
measurements, but that a dysregulation after lesion, albeit non-significant, is in line with previous
experiments [54]. Another plasticity related protein we tested, protein kinase Mξ (PKMξ), showed
similar non-significant variable results (data not shown). It was excluded from this study as its
significance for plasticity is controversially discussed [55–58]. Since activation of CaMKIIα is closely
associated with protein degradation and related to synaptic plasticity as well [38], we further evaluated
changes in protein homeostasis and investigated the other end of protein homeostasis, the protein
degradation systems and their effects on synaptic plasticity.
3.3. TBI-Induced Early Bidirectional Changes in the Activity of Two Protein Degradation Systems
Here, we present evidence that the activity of the proteasome as well as of autophagy is altered
early after TBI. While proteasome activity was significantly reduced in both hemispheres in CCI
animals compared to sham conditions, the analysis of autophagy showed a rise in the activity in the
ipsilateral hemisphere, while a decrease of activity could be observed in the contralateral hemisphere.
Thus, the focal brain injury seemed to trigger changes in protein homeostasis in the ipsilateral
hemisphere, which are comparable to observations made in ageing neural networks: Recently we
showed that in ageing, a shift from proteasome activity towards autophagy can be observed and this
mechanism was linked to differential modulation of chaperon Hsp-70 through BAG1/BAG3 [29–31].
Importantly, proteasome activity is crucial for synaptic plasticity both presynaptic and, prominently,
postsynaptic [59–62] as it is involved in turnover and function of neurotransmitter receptors, scaffolding
proteins in the post-synaptic density, post-synaptic signaling cascades [63] and protein translation [25].
Furthermore, impaired proteasome activity has been linked to neurodegenerative disorders such
as Alzheimer’s disease [64] and impaired learning [65]. Recent research showed that particularly
for l-LTP [66], proteasome activity, synergistically with brain-derived neurotrophic factor (BDNF),
is necessary for consolidation [67,68]. Autophagy is known to contribute to changes in synaptic
plasticity. While increased autophagy activation through mTOR inhibitors such as rapamycin [23,26,69]
as well as quantum dots [27] and increased autophagy through microwave radiation [70] reduced
LTP, also the reduction of autophagy might impair synaptic plasticity as it seems to be necessary for
LTP [71,72]. Together, this suggests that a sensitive balance between protein degradation systems
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but also within individual protein degradation systems is required to maintain synaptic plasticity.
To link these results to our electrophysiological data, we pharmacologically mimicked, in control
animals, the protein degradation impairments observed after lesion. The activity assays demonstrated
differential alterations of the two major protein degradation systems—while proteasome activity was
impaired, autophagy was increased, being suggestive of a shift between the two degradation systems.
We individually characterized these alterations by using pharmacological manipulation in control
animals to mimic the alterations observed in TBI. Administration of a proteasome inhibitor or an
autophagy activator lead to significantly impaired long-term synaptic plasticity in the somatosensory
cortex, and this is in line with research on the hippocampus [23,73].
3.4. Applicability and Future Directions
Concluding, with rising incidence of traumatic brain injury as a global major cause of mortality and
morbidity in human society, it is of great importance to better understand the early adaptive, cellular
mechanisms of functional reorganization of the ipsi- and contralateral cortex during the acute phase of
24–48 h after TBI. In order to be able to develop improved treatment options, a better understanding of
the pathophysiology of TBI is fundamental. In this regard, the present study provides new insights
into the cellular mechanisms that could mediate later cognitive impairments after TBI on the cellular
level. As we have shown here, the observed dysregulation of the proteasome degradation system early
after TBI contributed to an impaired function of neural networks, specifically to cellular processes
of learning and memory. Hence, our results could be applicable for further studies investigating
potentially new therapeutical strategies during the acute phase after TBI by modulating the observed
acute changes in protein homeostasis. With respect to the observed changes in long-term synaptic
plasticity, one might consider in vivo electrophysiological experiments with combined optogenetic
stimulation in a behavioral context in specific transgenic mouse lines to provide new insights into the
cellular mechanisms of TBI-induced chronic impairments of cognitive functions.
4. Materials and Methods
4.1. Animals and Ethical Statement
All experiments of this study were performed in strict accordance with the European regulations
and with the institutional guidelines of the Johannes Gutenberg University Mainz, Germany.
The protocol was approved by the Animal Ethics Committee of the Landesuntersuchungsamt
Rheinland-Pfalz (23 177-07/G 14-1-037). C57BL/6N wild-type mice of either sex at the age of 18–20 days
(n = 131; electrophysiology: n = 42, molecular biology: n = 81, histology: n = 8) were housed at a
constant room temperature of 23 ± 2 ◦C with a standard 12 h light/dark cycle and free access to food
and water. The number of animals was kept to a minimum and all efforts were made to minimize the
suffering of the mice.
4.2. Induction of Traumatic Brain Injury
Mice were initially anaesthetized with 4% isoflurane (AbbVie, Wiesbaden, Germany) and
anesthesia was continuously maintained throughout the surgery by inhalation of 1.5% isoflurane
mixed with oxygen. The mechanical brain trauma was induced as previously described in our lab by a
controlled cortical impact (CCI) [11,74]. In brief, the mice were placed in a stereotactic frame before
performing a 4 mm2 craniotomy over the right parietal sensorimotor cortex using a high-speed drill.
A stereotaxic impactor for CCI (Impact One™, Leica Mikrosysteme, Wetzlar, Germany) was used to
induce the mechanical trauma by positioning it perpendicular to the intact dura (impactor diameter:
1.5 mm, impact speed: 6 m/s, dwell time: 200 ms, impact depth: 0.8 mm). The previously removed
bone flap was subsequently repositioned and sealed with histoacryl surgical glue (B. Braun-Melsungen,
Melsungen, Germany) before sewing up the skin with polypropylene sutures (Ethicon, Somerville,
MA, USA). The isoflurane flux was interrupted to terminate anesthesia and animals were placed back
Int. J. Mol. Sci. 2019, 20, 3048 11 of 17
in their cage for at least 2 h recovery period under an infrared lamp. Sham-operated age-matched
littermates were used as controls to compare the different experimental conditions.
4.3. Electrophysiology In Vitro
4.3.1. Tissue Preparation
Animals were deeply anaesthetized with 4% isoflurane and decapitated at 1–2 days after lesion
induction. The brains were quickly removed and placed in 4 ◦C artificial CerebroSpinal Fluid (aCSF)
containing (in mM): 125 NaCl, 25 NaHCO3, 2.5 KCl, 1.5 MgCl2, 2 CaCl2, 1.25 NaH2PO4, and 25
D-glucose, equilibrated with 95% O2 and 5% CO2 (pH = 7.4). Acute coronal slices with a thickness
of 300 µm were prepared from the somatosensory cortex using a vibratome (Leica VT-1000-S, Leica
Mikrosysteme, Wetzlar, Germany) and incubated at room temperature for 15 min in oxygenated aCSF.
4.3.2. Multi-Electrode Array Recordings
Neuronal synaptic activity in the acute slices was recorded in both cortical hemispheres by use
of perforated Multi-Electrode Array chips (pMEA) (pMEA32S12 Layout 4, Multichannel Systems,
Reutlingen, Germany) equipped with 32 recording electrodes (4 rows of 8 electrodes) and 12 stimulating
electrodes (2 rows of 6 electrodes). The acute slices were transferred into a circular perfusion chamber
mounted on the pMEA chip and incubated for 90 min at 35 ◦C in oxygenated aCSF. Slices were carefully
positioned in order to put the recording electrodes below the supra-granular cortical layers 2/3 and one
row of stimulation electrodes in layer 4. To secure the position of the slice in the recording chamber
and improve contact between slices and electrodes, a low negative pressure (4–7 mbar) was constantly
applied through the perforation using a constant vacuum pump (Multi channel Systems, Reutlingen,
Germany). The center of the pMEA chip was placed at around 1 mm distance from the border of the
lesion and in homotopic regions when recorded in the contralateral hemisphere of injured animals
or in sham-operated mice. Each pMEA chip was used for multiple recordings of several brain slices
including measurements of CCI-treated animals and of the respective sham control.
All electrophysiological signals in the slices were acquired at 35 ◦C under constant perfusion of
oxygenated aCSF. The extracellularly recorded synaptic signals (field potentials, FP) were evoked
by stimulating afferent fibers in layer 4 using the integrated electrical stimulus generator of the
MEA2100-headstage (Multi channel Systems, Reutlingen, Germany). The stimulation pattern was
designed and controlled through MC_Rack and MC_Stimulus (Multichannel System, Reutlingen,
Germany) as a biphasic voltage signal (100 µs/phase). Baseline extracellular FPs were recorded every
60 s through a paired-pulse protocol (interpulse interval: 20 ms) for at least 30 min before long-term
potentiation (LTP) induction and were similar in all experimental groups. LTP was induced in slices by
adapting a theta-burst stimulation (TBS) protocol previously used in our lab [47]. The TBS protocol
consisted of three trains (at 30 s intervals) of five bursts (at 5 Hz) each providing four stimuli at 100 Hz.
In order to induce l-LTP, this TBS protocol was repeated four times with an intermission of 5 min.
The lesion-induced changes in long-term synaptic plasticity were assessed by applying paired-pulse
stimulations at 90 s intervals post-TBS. Raw signals were acquired, at a sampling rate of 50 kHz, with a
MEA2100-acquisition system. To optimize detection, the signal was band-pass filtered between 5 and
2500 Hz. Oﬄine analyses were performed with the software MC_Rack and pCLAMP 10 software
(Molecular Devices, Sunnyvale, CA, USA).
Pharmacological inhibition of the proteasome was induced by adding the proteasomal inhibitor
MG132 (Cayman Chemical, Ann Arbor, MI, USA) at a final concentration of 10 µM to the aCSF. Cortical
slices were incubated with MG132 for 60 min prior to the LTP-induction protocol (TBS), and afterwards
the bathing solution was switched back to normal aCSF. In order to activate autophagy in the cortical
slices, the tissue was perfused with aCSF containing rapamycin (Enzo, Farmingdale, NY, USA) at a
final concentration of 1 µM for 60 min pre-TBS and 30 min post-TBS. The bathing solution was then
switched back to aCSF for the rest of the recording period.
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4.4. Histology
Some brain slices (n = 4) were immediately fixated after the preparation by use of 4%
paraformaldehyde (Carl Roth, Karlsruhe, Germany) for 2 h. Cryoprotection was operated overnight
in 30% sucrose in phosphate-buffered saline (PBS) and the fixed brain slices were sectioned at 50 µm
using a microtome (Leica CM1325, Leica Mikrosysteme, Wetzlar, Germany). Brain sections were
Nissl-stained and subsequently mounted in Entellan® New (Merck Millipore, Billerica, MA, USA)
before imaging with a stereo microscope M205 FA (Leica Mikrosysteme, Wetzlar, Germany).
4.5. Western Blots
Protein quantification was performed with lysates from cortical probes prepared from regions
homotopic to the electrophysiological recordings from 12 mice for each condition (n = 36). Proteins
were electroblotted using 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
gel to a polyvinylidene difluoride (PVDF) membrane. The primary antibodies, CaMKII (C6974,
Sigma Aldrich, Saint-Louis, MO, USA), pCaMKII (#3361, Cell Signaling Technologies Inc., Danvers,
MA, USA) and GAPDH (A300-641A, Bethyl laboratories, Montgomery, AL, USA), were incubated
overnight at 4 ◦C. For detection, secondary horseradish peroxidase(HRP)-conjugated anti-rabbit
(A120-201C2, Dianova, Hamburg, Germany) was used and imaged using ECL detection solution
(Merck Millipore, Darmstadt Germany) and acquired with Image Lab 2.0 software (Bio-rad, Hercules,
CA, USA). Full uncut blots are provided in Figure S1.
4.6. Enzymatic Assays
4.6.1. Cell Death (TUNEL) Assay
After deep anesthesia with 4 % isoflurane, animals (n = 4) were sacrificed and the removed fresh
brains were flash frozen in pre-cooled 2-Methylbutane (Sigma-Aldrich, Saint-Louis, MO, USA). Frozen
brains were subsequently embedded in CryoGlue medium (SLEE medical, Mainz, Germany) and
coronal slices of the somatosensory cortex were performed (20 µm thick) using a freezing cryostat
(SLEE medical, Mainz, Germany). The In Situ Cell Death Detection Kit, TMR Red (Roche, Basel,
Switzerland) and the protocol from the supplier were used for the detection of cell death through the
labeling of DNA strand breaks. After staining, the slices were mounted in Immunoselect Antifading
Mounting Medium DAPI (SCR-38448, Dianova, Hamburg, Germany) and imaged with a confocal
microscope (Leica TCS SP5, Leica Mikrosysteme, Wetzlar, Germany).
4.6.2. Proteasome Activity Assay
Acute cortical slices (300 µm) from sham-operated and lesion-induced animals were prepared as
previously described and the cortical tissue of interest immediately dissected (at 1 mm from the border of
the lesion and in the homotopic region in contralateral hemisphere and sham-operated mice). The tissue
was ruptured in a lysis buffer containing (in mM): 10 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES), 10 potassium acetate, 1.45 magnesium acetate and 1 dithiothreitol (DTT) (pH = 7.6).
Samples were then incubated at 4 ◦C for 30 min and centrifuged at 5000 rpm for 5 min at 4 ◦C.
After the determination of total protein concentration, 10 µg of proteins were mixed in the assay
buffer containing (in mM): 15 HEPES, 130 potassium acetate, 1.5 magnesium acetate, 1.5 CaCl,
2 DTT, 8 adenosine triphosphate (ATP), 0.1 Suc-LLVY-AMC (Enzo Life Sciences, Farmingdale, NY,
USA). The reaction mix was then transferred to a 96 Well Polystyrene Black Microplate (Greiner
Bio-One, Kremsmünster, Austria) and placed in the Wallac 1420 VICTOR2 Microplate Reader (Perkin
Elmer, Waltham, MA, USA). After 2 h of incubation at 37 ◦C, the connected software enabled to
measure the 7-amino-4-methylcoumarin (AMC)-mediated fluorescence at 360 nm, as previously
described in our group [75]. For data analysis, the autofluorescence of the fluorogenic substrate was
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subtracted and the proteasome activities values of lesion samples were normalized to the one of sham:
Ratio = F (Lesion) × 100F (Sham) .
4.6.3. Autophagic Degradation Activity Assay
Acute cortical slices (300 µm) from sham operated and lesion-induced animals were prepared as
previously described and directly incubated for 2 h at room temperature either in aCSF or in aCSF
supplemented with 200 µM chloroquine, both equilibrated with 95% O2 and 5% CO2. After incubation,
the ipsi- and contralateral hemispheres were separated and flash-frozen in liquid nitrogen. Western
blot analysis was carried out as described previously [75]. Analysis was performed with the Fusion-SL
3500 WL system (Peqlab) and Aida Image Analyzer v.4v26 software (raytest). The following antibodies
were used: LC3B (L7543, Sigma-Aldrich) and Tubulin (T9026, Sigma-Aldrich).
4.7. Statistical Analysis
Results are presented as mean ± SEM. The statistical evaluation of the data was performed with
GraphPad Prism 7 (GraphPad Software, San Diego, CA, USA). To test for normal distribution of
the data, the Kolmogorov–Smirnov test in association with the Shapiro–Wilk test were performed.
If the data were normally distributed, one-way ANOVA and post hoc least significant difference
(LSD) were used to compare sham, lesion ipsilateral and lesion contralateral. In case data were
not normally distributed, a one-way Kruskal–Wallis test and pairwise Mann–Whitney U test were
employed. Significantly different values are indicated by asterisks in the figures (*: p < 0.05; **: p ≤ 0.01;
***: p ≤ 0.001).
4.8. Limitations
This study used an established ex vivo-in vitro model for traumatic brain injury, which is clinically
relevant [76]. However, one should keep in mind that the lissencephalic structure and the relatively
young age of the mice in the present study limits a direct applicability to the manifold variety of
traumatic brain injuries in humans. The role of TBI on long-term synaptic plasticity at laterstages
post-injury could not be investigated, since the electrophysiological results plus the induced strength
of l-LTP were different in older control mice. Furthermore, we observed a reduced survival rate in
more aged animals post TBI.
Supplementary Materials: Supplementary Materials can be found at http://www.mdpi.com/1422-0067/20/12/
3048/s1.
Author Contributions: Conceptualization: T.M., K.E., S.C.T., C.B., L.K.F., F.L., Data curation: L.K.F., F.L. and
V.F., Investigation L.K.F., F.L. and V.F., Methodology: L.K.F., F.L., Validation: T.M., C.B., K.E., S.C.T. Formal
Analysis: L.K.F., F.L., V.F., Visualization: L.K.F., F.L. and V.F., Writing—Original Draft Preparation, L.K.F. and
F.L., Writing—Review and Editing, T.M. and C.B., Resources K.E., S.C.T., C.B., T.M., Supervision, T.M., C.B., K.E.,
S.C.T., Project Administration, T.M., C.B., K.E., Funding Acquisition, T.M., C.B., K.E., L.K.F. and F.L. contributed
equally to the work. T.M. and C.B. contributed equally to the work.
Acknowledgments: We would like to thank Simone Dahms-Prätorius for technical assistance, and support by the
IMB, Mainz is gratefully acknowledged. This work is supported by the German Research Foundation (DFG, CRC
1080 to T.M. (TP C02), C.B. (TP B09) and K.E. (TP A07), and CRC1177 to C.B.) and by a grant of the FTN-Mainz to LKF.
Conflicts of Interest: The authors declare no conflict of interest.
Abbreviations
aCSF artificial cerebrospinal fluid
AMC 7-amino-4-methylcoumarin
ATP Adenosine triphosphate
BAG Beclin2-associated anthanogene
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References
1. Tagliaferri, F.; Compagnone, C.; Korsic, M.; Servadei, F.; Kraus, J. A systematic review of brain injury
epidemiology in Europe. Acta Neurochir. 2006, 148, 255–268. [CrossRef] [PubMed]
2. Rozenbeek, B.; Maas, A.I.R.; Menon, D.K. Changing patterns in the epidemiology of traumatic brain injury.
Nat. Rev. Neurol. 2013, 9, 231–236. [CrossRef] [PubMed]
3. Mckee, A.C.; Daneshvar, D.H. The neuropathology of traumatic brain injury. Handb. Clin. Neurol. 2015, 127,
45–66. [PubMed]
4. Nortje, J.; Menon, D.K. Traumatic brain injury: Physiology, mechanisms, and outcome. Curr. Opin. Neurol.
2004, 17, 711–718. [CrossRef] [PubMed]
5. Robbins and Cotran. Pathologic Basis of Disease, 8th ed.; Saunders by Elsevier: Philadelphia, PA, USA, 2010;
pp. 1287–1290.
6. Gadani, S.P.; Walsh, J.T.; Lukens, J.R.; Kipnis, J. Dealing with Danger in the CNS: The Response of the
Immune System to Injury. Neuron 2015, 87, 47–62. [CrossRef] [PubMed]
7. Zhang, X.; Chen, Y.; Jenkins, L.W.; Kochanek, P.M.; Clark, R.S.B. Bench-to-bedside review: Apoptosis/programmed
cell death triggered by traumatic brain injury. Crit. Care 2015, 9, 66–75. [CrossRef] [PubMed]
8. Walker, K.R.; Tesco, G. Molecular mechanisms of cognitive dysfunction following traumatic brain injury.
Front. Aging Neurosci. 2013, 5, 29. [CrossRef] [PubMed]
9. Guerriero, R.M.; Giza, C.C.; Rotenberg, A. Glutamate and GABA imbalance following traumatic brain injury.
Curr. Neurol. Neurosci. Rep. 2015, 15, 27. [CrossRef]
10. Imbrosci, B.; Wang, Y.; Arckens, L.; Mittmann, T. Neuronal mechanisms underlying transhemispheric
diaschasis following focal cortical injuries. Brain Struct. Funct. 2015, 220, 1649–1664. [CrossRef]
11. Le Prieult, F.; Thal, S.C.; Engelhard, K.; Imbrosci, B.; Mittmann, T. Acute Cortical Transhemispheric Diaschisis
after Unilateral Traumatic Brain Injury. J. Neurotrauma 2017, 34, 1097–1110. [CrossRef]
12. Buetefisch, C.M.; Kleiser, R.; Seitz, R.J. Post-lesional cerebral reorganization: Evidence from functional
neuroimaging and transcranial magnetic stimulation. J. Physiol. Paris 2006, 99, 437–454. [CrossRef] [PubMed]
Int. J. Mol. Sci. 2019, 20, 3048 15 of 17
13. Wakade, C.; SukumariRamesh, S.; Laird, M.D.; Dhandapani, K.M.; Vender, J.R. Delayed reduction in
hippocampal postsynaptic density protein-95 expression temporally correlates with cognitive dysfunction
following controlled cortical impact in mice. J. Neurosurg. 2011, 113, 1195–1201. [CrossRef] [PubMed]
14. Schwartz, J.H. Neurotransmitters. In Principles of Neural Science, 4th ed.; Elsevier Science Publishing Co., Inc.:
New York, NY, USA, 2000; pp. 280–297.
15. Castillo, P.E. Presynaptic LTP and LTD of Excitatory and Inhibitory Synapses. Cold Spring Harb. Perspect. Biol.
2012, 4, a005728. [CrossRef] [PubMed]
16. Nowak, L.; Bregestovski, P.; Ascher, P.; Herbet, A.; Prochiantz, A. Magnesium gates glutamate-activated
channels in mouse central neurones. Nature 2011, 307, 462–465. [CrossRef] [PubMed]
17. Bliss, T.V.P.; Cooke, S.F. Long-term potentiation and long-term depression: A clinical perspective.
Clin. (Sao Paulo) 2011, 66, 3–17. [CrossRef] [PubMed]
18. Lisman, J.; Yasuda, R.; Raghavachari, S. Mechanisms of CaMKII action in long-term potentiation.
Nat. Rev. Neurosci. 2012, 13, 169–182. [CrossRef]
19. Redondo, R.L.; Morris, R.G. Making memories last: The synaptic tagging and capture hypothesis.
Nat. Rev. Neurosci. 2011, 12, 17–30. [CrossRef]
20. Malinow, R.; Malenka, R.C. AMPA receptor trafficking and synaptic plasticity. Annu. Rev. Neurosci. 2002, 25,
103–126. [CrossRef]
21. Lisman, J.; Schulman, H.; Cline, H. The molecular basis of CaMKII function in synaptic and behavioural
memory. Nat. Rev. Neurosci. 2002, 3, 175–190. [CrossRef]
22. Byth, L.A. Ca2+- and CaMKIImediated processes in early LTP. Ann. Neurosci. 2014, 21, 151–153. [CrossRef]
23. Fonseca, R.; Vabulas, R.M.; Hartl, F.U.; Bonhoeffer, T.; Nägerl, U.V. A balance of protein synthesis and
proteasome-dependent degradation determines the maintenance of LTP. Neuron 2006, 52, 239–245. [CrossRef]
[PubMed]
24. Cai, F.; Frey, J.U.; Sanna, P.P.; Behnisch, T. Protein degradation by the proteasome is required for synaptic
tagging and the heterosynaptic stabilization of hippocampal latephase longterm potentiation. Neuroscience
2010, 169, 1520–1526. [CrossRef] [PubMed]
25. Dong, C.; Bach, S.V.; Haynes, K.A.; Hegde, A.N. Proteasome modulates positive and negative translational
regulators in long-term synaptic plasticity. J. Neurosci. 2014, 34, 3171–3182. [CrossRef] [PubMed]
26. Ghighlieri, V.; Pendolino, V.; Bagetta, V.; Sgobio, C.; Calabresi, P.; Picconi, B. mTOR inhibitor rapamycin
suppresses striatal postischemic LTP. Exp. Neurol. 2010, 226, 328–331. [CrossRef] [PubMed]
27. Chen, L.; Miao, Y.; Chen, L.; Jin, P.; Zha, Y.; Chai, Y.; Zheng, F.; Zhang, Y.; Zhuo, W.; Zhand, J.; et al. The role
of elevated autophagy on the synaptic plasticity impairment caused by CdSe/ZnS quantum dots. Biomaterials
2013, 34, 10172–10181. [CrossRef] [PubMed]
28. Hernandez, D.; Torres, C.A.; Setlik, W.; Cebrián, C.; Mosharov, E.V.; Tang, G.; Cheng, H.C.; Yarygina, O.;
Burke, R.E.; Gershon, M.; et al. Regulation of Presynaptic Neurotransmission by Macroautophagy. Neuron
2012, 47, 277–284. [CrossRef]
29. Gamerdinger, M.; Carra, S.; Behl, C. Emerging roles of molecular chaperones and co-chaperones in selective
autophagy: Focus on BAG proteins. J. Mol. Med. 2011, 89, 1175–1182. [CrossRef]
30. Behl, C. Breaking BAG: The Co-Chaperone BAG3 in Health and Disease. Trends Pharm. Sci. 2016, 37, 672–688.
[CrossRef]
31. Morawe, T.; Hiebel, C.; Kern, A.; Behl, C. Protein Homeostasis, Aging and Alzheimer’s Disease. Mol. Neurobiol.
2012, 46, 41–54. [CrossRef]
32. Behl, C. BAG3 and friends Co-chaperones in selective autophagy during aging and disease. Autophagy 2011,
7, 795–798. [CrossRef]
33. Yao, X.; Liu, J.; McCabe, J.T. Alterations of cerebral cortex and hippocampal proteasome subunit expression
and function in a traumatic brain injury rat model. J. Neurochem. 2007, 104, 353–363. [CrossRef] [PubMed]
34. Sakai, K.; Fukuda, T.; Iwadate, K. Immunohistochemical analysis of the ubiquitin proteasome system and
autophagy lysosome system induced after traumatic intracranial injury: Association with time between the
injury and death. Am. J. Forensic Med. Pathol. 2014, 35, 38–44. [CrossRef] [PubMed]
35. Clark, R.S.; Bayir, H.; Chu, C.T.; Alber, S.M.; Watkins, S.C. Autophagy is increased in mice after traumatic
brain injury and is detectable in human brain after trauma and critical illness. Autophagy 2008, 4, 88–90.
[CrossRef] [PubMed]
Int. J. Mol. Sci. 2019, 20, 3048 16 of 17
36. Sarkar, C.; Zhao, Z.; Aungst, S.; Sabirzhanov, B.; Faden, A.I.; Lipinski, M.M. Impaired autophagy flux is
associated with neuronal cell death after traumatic brain injury. Autophagy 2014, 10, 2208–2222. [CrossRef]
[PubMed]
37. Yin, Y.; Li, E.; Sun, G.; Yan, H.; Foley, L.; Andrzejczuk, L.; Attarwala, I.; Hitchens, T.; Kiselyov, K.; Dixon, C.;
et al. Effects of DHA on Hippocampal Autophagy and Lysosome Function After Traumatic Brain Injury.
Mol. Neurobiol. 2017, 55, 1–17. [CrossRef] [PubMed]
38. Cajigas, I.J.; Will, T.; Schuman, E.M. Protein homeostasis and synaptic plasticity. EMBO J. 2010, 29, 2746–2752.
[CrossRef] [PubMed]
39. Graves, A.B.; White, E.; Koepsell, T.D.; Reifler, B.V.; van Belle, G.; Larson, E.B.; Raskind, M. The association
between head trauma and Alzheimer’s disease. Am. J. Epidemiol. 1990, 131, 491–501. [CrossRef]
40. Mayeux, R.; Ottman, R.; Maestre, G.; Ngai, C.; Tang, M.X.; Ginsberg, H.; Tycko, B.; Shelanski, M. Synergistic
effects of traumatic head injury and apolipoprotein-epsilon 4 in pateints with Alzheimer’s disease. Neurology
1995, 45, 555–557. [CrossRef]
41. Graham, D.I.; Gentleman, S.M.; Lynch, A.; Roberts, G.W. Distribution of beta-amyloid protein in the brain
following severe head injury. Neuropathol. Appl. Neurobiol. 1995, 21, 27–34. [CrossRef] [PubMed]
42. Guo, Z.; Cupples, L.A.; Kurz, A.; Auerbach, S.H.; Volicer, L.; Chui, H.; Green, R.C.; Sadovnick, A.D.; Duara, R.;
DeCarli, C.; et al. Head injury and risk of AD in the MIRAGE study. Neurology 2000, 54, 1316–1323. [CrossRef]
43. Johnson, V.E.; Stewart, W.; Smith, D.H. Widespread τ and amyloid-β pathology many years after traumatic
brain injury in humans. Brain Pathol. 2012, 22, 142–149. [CrossRef] [PubMed]
44. Ojo, J.O.; Mouzon, B.; Greenberg, M.B.; Bachmeier, C.; Mullan, M.; Crawford, F. Repetitive mild traumatic
brain injury augments tau pathology and glial activation in aged hTau mice. J. Neuropathol. Exp. Neurol.
2013, 72, 137–151. [CrossRef]
45. Mittmann, T.; Eysel, U.T. Increased synaptic plasticity in the surround of visual cortex lesions in rats.
Neuroreport 2001, 12, 3341–3347. [CrossRef]
46. Huemmeke, M.; Eysel, U.T.; Mittmann, T. Metabotropic glutamate receptors mediate expression of LTP in
slices of rat visual cortex. Eur. J. Neurosci. 2002, 15, 1641–1645. [CrossRef]
47. Dohle, C.I.; Eysel, U.T.; Mittmann, T. Spatial distribution of long-term potentiation in the surround of visual
cortex lesions in vitro. Exp. Brain Res. 2009, 199, 423–433. [CrossRef] [PubMed]
48. Imbrosci, B.; Mittmann, T. Functional consequences of the disturbances in the GABA-mediated inhibition
induced by injuries in the cerebral cortex. Neural Plast. 2011, 2011, 614329. [CrossRef]
49. Cantu, D.; Walter, K.; Andresen, L.; TaylorWeiner, A.; Hampton, D.; Tesco, G.; Dulla, C.G. Traumatic brain
injury increases cortical glutamate network activity by compromising GABAergic control. Cereb. Cortex 2015,
25, 2306–2320. [CrossRef] [PubMed]
50. Reeves, T.M.; Lyeth, B.G.; Povlishock, J.T. Longterm potentiation deficits and excitability changes following
traumatic brain injury. Exp. Brain Res. 1995, 106, 248–256. [CrossRef]
51. Sanders, M.J.; Sick, T.J.; PerezPinzon, M.A.; Dietrich, W.D.; Green, E.J. Chronic failure in the maintenance of
longterm potentiation following fluid percussion injury in the rat. Brain Res. 2000, 861, 69–76. [CrossRef]
52. Schwarzbach, E.; Bonislawski, D.P.; Xiong, G.; Cohen, A.S. Mechanisms underlying the inability to induce
area CA1 LTP in the mouse after traumatic brain injury. Hippocampus 2006, 16, 541–550. [CrossRef]
53. Fineman, I.; Hovda, D.A.; Smith, M.M.; Yoshino, A.; Becker, D.P. Concussive brain injury is associated
with a prolonged accumulation of calcium: A 45Ca2+ autoradiographic study. Brain Res. 1993, 624, 94–102.
[CrossRef]
54. Atkins, C.M.; Chen, S.; Alonso, O.F.; Dietrich, W.D.; Hu, B.R. Activation of calcium/calmodulin-dependent
protein kinases after traumatic brain injury. J. Cereb. Blood Flow Metab. 2006, 26, 1507–1518. [CrossRef]
[PubMed]
55. Hu, J.Y.; Baussi, O.; Levine, A.; Chen, Y.; Schacher, S. Persistent longterm synaptic plasticity requires activation
of a new signaling pathway by additional stimuli. J. Neurosci. 2011, 31, 8841–8850. [CrossRef]
56. Hu, J.Y.; Adler, K.; Farah, C.A.; Hastings, M.H.; Sossin, W.S.; Schacher, S. CellSpecific PKM Isoforms
Contribute to the Maintenance of Different Forms of Persistent Long-Term Synaptic Plasticity. J. Neurosci.
2017, 37, 2476–2763. [CrossRef]
57. Shao, C.Y.; Sondhi, R.; van de Nes, P.S.; Sacktor, T.C. PKMζ is necessary and sufficient for synaptic clustering
of PSD95. Hippocampus 2012, 22, 1501–1507. [CrossRef] [PubMed]
Int. J. Mol. Sci. 2019, 20, 3048 17 of 17
58. Volk, L.J.; Bachmann, J.L.; Johnson, R.; Yu, Y.; Huganir, R.L. PKMζ is not required for hippocampal synaptic
plasticity, learning and memory. Nature 2013, 493, 420–423. [CrossRef] [PubMed]
59. Lopez-Salon, M.; Alonso, M.; Vianna, M.R.; Viola, H.; Mello e Souza, T.; Izguierdo, I.; Pasquini, J.M.;
Medina, J.H. The ubiquitin-proteasome cascade is required for mammalian long-term memory formation.
Eur. J. Neurosci. 2001, 14, 1820–1826. [CrossRef]
60. Tai, H.C.; Schuman, E.M. Ubiquitin, the proteasome and protein degradation in neuronal function and
dysfunction. Nat. Rev. Neurosci. 2008, 9, 826–838. [CrossRef]
61. Mabb, A.M.; Ehlers, M.D. Ubiquitination in postsynaptic function and plasticity. Annu. Rev. Cell. Dev. Biol.
2010, 26, 179–210. [CrossRef]
62. Jarome, T.J.; Helmstetter, F.J. The ubiquitin-proteasome system as a critical regulator of synaptic plasticity
and long-term memory formation. Neurobiol. Learn. Mem. 2013, 105, 107–116. [CrossRef]
63. Tsai, N.P. Ubiquitin proteasome system-mediated degradation of synaptic proteins: An update from the
postsynaptic side. Biochim. Biophys. Acta 2014, 1843, 2838–2842. [CrossRef] [PubMed]
64. Ross, C.A.; Poirier, M.A. Protein aggregation and neurodegenerative disease. Nat. Med. 2004, 10, 10–17.
[CrossRef]
65. Sunkaria, A.; Yadav, A.; Bhardwaj, S.; Sandhir, R. Postnatal Proteasome Inhibtion Promotes Amyloid-β
Aggregation in Hippocampus and Impairs Spatial Learning in Adult Mice. Neuroscience 2017, 367, 47–59.
[CrossRef]
66. Dong, C.; Upadhya, S.C.; Ding, L.; Smith, T.K.; Hegde, A.N. Proteasome inhibition enhances the induction
and impairs the maintenance of late-phase long-term potentiation. Learn. Mem. 2008, 15, 335–347. [CrossRef]
67. Edelmann, E.; Lessmann, V.; Brigadski, T. Pre- and postsynaptic twists in BDNF secretion and action in
synaptic plasticity. Neuropharmacology 2014, 76, 610–627. [CrossRef] [PubMed]
68. Santos, A.R.; Mele, M.; Vaz, S.H.; Kellermayer, B.; Grimaldi, M.; Colino-Oliveira, M.; Rombo, D.M.;
Comprido, D.; Sebastiao, A.M.; Duarte, C.B. Differential Role of the Proteasome in the Early and Late Phases
of BDNF-Induced Facilitation of LTP. J. Neurosci. 2015, 35, 3319–3329. [CrossRef]
69. Stoica, L.; Zhu, P.J.; Huang, W.; Zhou, H.; Kozma, S.C.; CostaMattioli, M. Selective pharmacogenetic inhibition
of mammalian target of Rapamycin complex I (mTORC1) blocks longterm synaptic plasticity and memory
storage. Proc. Natl. Acad. Sci. USA 2011, 108, 3791–3796. [CrossRef] [PubMed]
70. Hao, Y.; Li, W.; Wang, H.; Zhang, J.; Yu, C.; Tan, S.; Wang, H.; Xu, X.; Dong, J.; Yao, B.; et al. Autophagy
mediates the degradation of synaptic vesicles: A potential mechanism of synaptic plasticity injury induced
by microwave exposure in rats. Physiol. Behav. 2018, 188, 119–127. [CrossRef]
71. Blockaert, J.; Marin, P. mTOR in Brain Physiology and Pathologies. Physiol. Rev. 2015, 95, 1157–1187.
[CrossRef] [PubMed]
72. Glatigny, M.; Moriceau, S.; Rivagorda, M.; Ramos-Brossier, M.; Nascimbeni, A.C.; Lante, F.; Shanley, M.R.;
Boudarene, N.; Rousseaud, A.; Friedman, A.K.; et al. Autophagy Is Required for Memory Formation and
Reverses Age-Related Memory Decline. Curr. Biol. 2019, 29, 435–448. [CrossRef]
73. Karpova, A.; Mikhaylova, M.; Thomas, U.; Knöpfel, T.; Behnisch, T. Involvement of Protein Synthesis and
Degradation in Long-Term Potentiation of Schaffer Collateral CA1 Synapses. J. Neurosci. 2006, 26, 4949–4955.
[CrossRef] [PubMed]
74. Thal, S.C.; Wyschkon, S.; Pieter, D.; Engelhard, K.; Werner, C. Selection of endogenous control genes for
normalization of gene expression analysis after experimental brain trauma in mice. J. Neurotrauma 2008, 25,
785–794. [CrossRef] [PubMed]
75. Renziehausen, J.; Hiebel, C.; Nagel, H.; Kundu, A.; Kins, S.; Kögel, D.; Behl, C.; Hajieva, P. The cleavage
product of amyloid-β protein precursor sAβPPα modulates BAG3-dependent aggresome formation and
enhances cellular proteasomal activity. J. Alzheimers Dis. 2015, 44, 879–896. [CrossRef] [PubMed]
76. Xiong, Y.; Mahmood, A.; Chopp, M. Animal models of traumatic brain injury. Nat. Rev. Neurosci. 2013, 14,
128–139. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
